Both Wajapeyee et al. (2008) and Acosta et al. (2008) used loss-of-function screens in cultured diploid human fibroblasts to identify genes required to induce senescence. Wajapeyee et al. made use of an oncogenic allele of the serine/threonine kinase BRAF (BRAF V600E ) that contains a mutation known to occur with high frequency in malignant melanomas. After confirming that the expression of BRAF V600E in the fibroblasts was sufficient to induce senescence and apoptosis, the authors introduced into the BRAF V600E -expressing cells a short hairpin RNA (shRNA) library targeting human genes. Using this approach, they identified 17 genes whose suppression permitted the cells to proliferate in the presence of BRAF V600E . Of these genes, one encoded the insulin-like growth factor binding protein 7 (IGFBP7), a secreted protein previously implicated in senescence in breast cancer cells (Wilson et al., 2002) . IGFBP7 is a low-affinity insulin-like growth factor (IGF) binding protein (Burger et al., 2005) . Although it is not known whether IGFBP7 mediates its effects by binding and suppressing IGF proteins, it is notable that IGFs have long been suspected to promote tumorigenesis. Indeed, therapeutic strategies focused on inhibiting the IGF signaling pathway are currently under development.
Wajapeyee and colleagues showed that BRAF V600E upregulated IGFBP7 expression at least in part through stimulating the binding of the transcription factor activator protein 1 (AP-1) to the IGFBP7 promoter. Consistent with the hypothesis that IGFBP7 suppresses BRAF-driven tumor development in vivo, melanomas that harbored BRAF V600E mutations exhibited hypermethylation of a CpG island in the IGFBP7 promoter relative to either benign lesions (nevi) that harbored BRAF V600E or melanomas that lacked the BRAF V600E oncogene. Interestingly, cultured melanocytes expressing BRAF V600E were sensitive to IGFBP7 in the culture media, which was sufficient to induce apoptosis. Taken together, these observations implicate IGFBP7 as an essential component of an autocrine/paracrine feedback loop that constrains BRAF V600E -stimulated cell proliferation.
Unexpected Pieces to the Senescence Puzzle
Although initially described as the end state of cells after extended rounds of division in culture, it is now clear that cellular senescence induced by different stimuli plays an important role in tumor suppression in vivo. Three recent studies in Cell report that secreted proteins play an important role in enforcing the senescence response (Acosta et al., 2008; Kuilman et al., 2008; Wajapeyee et al., 2008) . These new studies identify unanticipated contributors to this tumor-suppressing cell state. Acosta et al. (2008) used a similar approach to search for genes that extended the life span of IMR-90 cultured human fibroblasts and found that the chemokine receptor CXCR2 was required for replicative senescence and oncogene-induced senescence. Furthermore, overexpression of CXCR2 or the CXCR2 ligands interleukin-8 (IL-8) and GROα/Gro-1 led to a proliferative arrest that was dependent upon the expression of p53. Notably, expression of oncogenic RAS was previously shown to enhance Gro-1 expression and to induce senescence of murine stromal fibroblasts, underscoring the importance of this chemokine secretory response in senescence (Yang et al., 2006) . Indeed, these CXCR2 ligands were also found to be upregulated in cells rendered senescent by mitogen-activated kinase kinase (MEK) activation. Using small-molecule inhibitors, Acosta et al. further demonstrated that blocking the p38 and NF-κB pathways suppressed the observed induction of IL-8 expression by MEK. Finally, they showed that CXCR2 is upregulated in benign lesions such as chemically induced papillomas and prostate intraepithelial neoplastic lesions, suggesting that this pathway is upregulated in spontaneously arising premalignant lesions.
In their new work, Kuilman et al. (2008) used whole-genome transcriptional analyses of cell lines expressing BRAF V600E in their search for senescence factors. Similar to what has been previously reported for replicative senescence (reviewed in Campisi and d'Adda di Fagagna, 2007) , they found that of the many transcriptional changes observed in senescent cells, a significant number of the upregulated genes were involved in chemokine and cytokine signaling. In particular, Kuilman et al. found that IL-6 was reproducibly upregulated in BRAF V600E -expressing cells, and they verified that suppression of IL-6 or its cognate receptor IL-6R was sufficient to allow these cells to re-enter the cell cycle and to proliferate, thereby bypassing oncogene-induced senescence. However, overexpression of IL-6 alone was not sufficient to induce senescence, suggesting that IL-6 acts in concert with other factors to initiate senescence. Indeed, the suppression of IL-8 resulted in similar biological effects as the suppression of IL-6. Kuilman et al. further showed that the levels of the transcription factors C/EBP (CCAAT-enhancer-binding proteins) increased in oncogeneinduced senescence. They determined by chromatin immunoprecipitation that C/EBP was present at both the IL-6 and IL-8 promoters, suggesting a likely mechanism for the upregulation of these cytokines in senescence. Moreover, they found that IL-6 and C/EBP function in a positive feedback loop; both are required to amplify and sustain the inflammatory network and senescence. Importantly, similar to the findings of Acosta et al. (2008) , Kuilman and colleagues showed that the expression of IL-8 correlated with a nonproliferative phenotype in colonic adenomas, supporting the possibility that these cytokines function in vivo to promote cell senescence in benign human tumors.
Although each of these three studies identified different genes involved in the senescence response, the common theme that emerges is that secreted proteins play a critical role in the induction and maintenance of some forms of oncogeneinduced senescence. Although surprising, these observations provide new insights into our understanding of oncogene-induced senescence. So, how do these findings interface with our current mechanistic understanding of oncogene-induced senescence and human tumor development?
Connections with Known Mediators of Senescence
At least three cellular responses to oncogenic stress have been proposed to mediate oncogene-induced senescence: heterochromatin formation, activation of the DNA-damage response, and negative feedback suppression of oncogenic signaling pathways (reviewed in Campisi and d'Adda di Fagagna, 2007; Courtois-Cox et al., 2006) . Importantly, these mechanisms of oncogene-induced senescence are not mutually exclusive and all of these processes are intimately connected to the activity of the RB and p53 pathways. The derepression of the INK4/ARF locus is one mechanism known to contribute to the activation of RB and p53 and to play a critical role in initiating and maintaining the senescence response. However, several lines of evidence suggest that additional cooperative signals may exist. Although the details differ among these studies, the secreted proteins featured herein appear to provide such cooperative signals and to converge with each of the existing senescence models (Figure 1) .
Heterochromatin Formation
Although no universal marker of senescence has been described, many senescent cells undergo dramatic changes in chromatin structure and form easily visualized senescenceassociated heterochromatic foci (Narita et al., 2003) . The for- -dependent senescence. These unexpected observations provide new insights into the overlapping yet distinct mechanisms of activation of the p53 and RB tumor suppressor pathways that induce the senescence response. IGFBP7 expression is mediated by the transcription factor activator protein 1 (AP-1; blue). IGFBP7 inhibits the MEK mitogenactivated protein kinase pathway via the upregulation of the Raf inhibitory protein (RKIP) but in contrast promotes expression of p16. The transcription factor C/EBP (CCAAT-enhancer-binding protein; blue) promotes expression of IL-6. The activity of the cytokine is mediated by its receptor IL-6R. The chemokine receptor CXCR or its ligands IL-8 and GRO-α promote p53-dependent senescence. IL-8 upregulation is dependent upon the transcripton factors C/EBP and NF-κB. mation of these foci requires the recruitment of RB and heterochromatin proteins (Adams, 2007; Narita et al., 2003) . This provides a plausible mechanism for the stable suppression of E2F target genes and other genes necessary to enforce an irreversible senescent state. One RB pathway regulator, p16 INK4a , has been shown to be essential for oncogene-induced senescence in vivo and in vitro. However, others have noted that p16
INK4a is not expressed in every senescent cell within BRAF V600E -expressing melanocytic nevi, supporting the notion that other signals contribute to the activation of RB in some settings (Michaloglou et al., 2005) . One such signal may be the cyclin kinase inhibitor p15
INK4b , which was identified as a marker of Ras-induced senescence (Collado et al., 2005) . The work of Kuilman et al. (2008) provides an interesting link between p15
INK4b , heterochromatin, and the IL-6/C/EBP pathway. Specifically, inactivation of IL-6 or C/EBP not only prevented the proliferative arrest triggered by oncogenic BRAF V600E but also inhibited p15
INK4b expression and senescence-associated heterochromatic foci formation. Notably, C/EBP has previously been shown to bind and activate the p15
INK4b promoter (Gomis et al., 2006) , providing a mechanistic explanation for these findings. Taken together, these observations suggest that IL-6 and C/EBP coordinately function to upregulate p15
INK4b expression, which in turn contributes toward RB activation, senescenceassociated heterochromatic foci formation, and oncogeneinduced senescence.
DNA Damage
Oncogene-induced senescence can be mediated by DNA damage associated with replicative stress or the accumulation of reactive oxygen species (ROS) (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007) . Following the identification of CXCR as a factor involved in senescence, Acosta and coworkers directly explored a role for chemokine signaling in the DNA-damage response. Specifically, they showed that inactivation of CXCR2 inhibited the DNA-damage response and abrogated the proliferative arrest of irradiated fibroblasts. In addition, CXCR2-induced senescence and senescenceassociated heterochromatic foci formation depended on functional p53 (in murine cells) or p53 and RB (in human cells). Further work is necessary to decipher the effects of CXCR2 ablation on the DNA-damage response and on p53 expression in response to oncogenic stress. However, these observations do suggest that excessive CXCR signaling during oncogeneinduced senescence may allow for increased ROS accumulation, thus promoting the DNA-damage response and sustained activation of p53. Negative Feedback Signaling Wajapeyee et al. suggest that IGFBP7 mediates its antiproliferative effects via the induction of a negative feedback signaling response. Specifically, they showed that conditioned media from IGFBP7-expressing cells or recombinant IGFBP7 purified from baculovirus-infected insect cells potently suppressed the activation of the mitogen-activated protein kinase (MAPK) ERK. Moreover, they demonstrated that this suppressive effect in melanoma cells was largely mediated by the upregulation of Raf inhibitory protein (RKIP), a protein that disrupts the interaction between upstream activators of ERK, Raf, and MEK. Importantly, the antiproliferative effects of IGFBP7 in melanoma cells were suppressed by the ectopic expression of an activated ERK2 or MEK allele. Thus, Wajapeyee et al. concluded that the suppression of cell proliferation conferred by IGFBP7 is mediated, in part, by a negative feedback signal that emanates from the initial oncogenic insult. These findings are conceptually similar to another report demonstrating that a negative feedback signaling network involving multiple negative regulatory genes is activated by an oncogenic allele of RAF during oncogene-induced senescence (Courtois-Cox et al., 2006) . Given that other studies have demonstrated that perturbation of components of the Ras/phosphatidylinositol 3-kinase (PI3K) signaling pathways also contributes to oncogene-induced senescence (Chen et al., 2005; Courtois-Cox et al., 2006) , perhaps negative feedback suppression of both the MEK/ERK and PI3K pathways cooperate to mediate senescence and tumor suppression. This model is supported by the observation that both the ERK and PI3K pathways are inactive in some benign human tumors (Courtois-Cox et al., 2006) .
Mediating Senescence by A Threshold Response
The process of oncogene-induced senescence appears to be dependent on a rapidly growing list of genes. How then is it possible that the inactivation of any one gene can block senescence? There are two nonmutually exclusive possibilities. First, although it is clear that p53-and RB-regulated senescence can be induced by many stimuli, the activation of the p53 or RB cell-cycle checkpoint under normal cellular contexts fails to induce a senescence response. Therefore, it is likely that an enhancement of the amplitude and/or duration of the Rb/p53 signal, above a certain threshold, is necessary to trigger an irreversible proliferative arrest. For example, although p16
INK4a
is certainly an important regulator of oncogene-induced senescence, it is possible that other cyclin kinase inhibitors such as p15
INK4b reinforce and amplify this signal. Similarly, the DNAdamage response pathway serine/threonine kinase ATM and the p53 regulator ARF may collaborate in response to certain oncogenic insults to potentiate p53 activation (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007) .
A second possibility is that the activation of pathways linked to senescence triggers a positive feedback loop necessary to enforce the senescence response. Indeed, Kuilman and colleagues demonstrated that the cytokine IL-6 and C/EBP form this type of feedback loop and observed that in the absence of either of these two proteins, the entire network of signaling pathways that regulate the inflammatory response is disrupted.
Although such thresholds and feedback loops in this system are as yet incompletely defined, these models could explain how multiple different signals may cooperate to induce the senescence response in different contexts. If the threshold response model is correct, the level and strength of oncogenic signals should be carefully considered when interpreting studies of oncogene-induced senescence. In addition, whereas the term oncogene-induced senescence is generally used to describe senescence triggered by any oncogenic insult, it is likely that specific oncogenes may be attenuated by different inhibitory signals. Consistent with this notion, Wajapeyee et al.
showed that melanomas expressing a mutant RAS allele were much less sensitive to the inhibitory effects of IGFBP7 relative to melanomas harboring the BRAF V600E allele. Regardless of the details of how senescence may be initiated, these new findings have important implications for our understanding of tumor progression. Inactivation of any one of the proteins identified in the three screens in a specific setting may allow premalignant cells to bypass oncogene-induced senescence and thereby contribute toward the development of a malignant lesion. Thus, identification of signals that promote senescence in a given tumor type may provide new therapeutic targets for cancer. The observation that mice harboring human tumor xenografts treated with recombinant IGFBP7 show tumor growth suppression lends support to this possibility (Wajapeyee et al., 2008) .
The genes identified in these studies clearly act to promote senescence in an autocrine manner because the gene products are secreted factors. However, it is also necessary to consider the consequences of upregulating these genes in situ. In particular, it has been reported that senescent cells can induce their own clearance (Xue et al., 2007) . Alternatively, senescent cells have also been observed to elicit effects on the tumor stroma that serve to enhance tumor growth (Krtolica et al., 2001 ). Thus, depending on the context, these secreted proteins may also serve to inhibit or to enhance cancer initiation and progression in addition to enforcing oncogene-induced senescence in a cell-autonomous manner. Despite the recent rapid progress in deciphering the molecular regulators and components of senescence, it is clear that we have only begun to unravel the complex regulation of cell senescence and its role in tumor suppression.
